What is the prevalence of Legionnaires' Disease?

Legionnaires' disease is an acute respiratory infection caused by Legionella bacteria, with an estimated annual incidence of 10,000 to 18,000 cases in the United States, though true prevalence is likely significantly higher due to underdiagnosis. Because it is an acute, environmentally acquired infection rather than a chronic genetic condition, it is typically classified as an infectious disease of public health concern rather than a rare or ultra-rare disease.

How common is Legionnaires' disease?

While Legionnaires' disease is not considered a rare disease in the clinical sense, it is often underreported. According to the Centers for Disease Control and Prevention (CDC), the incidence of reported Legionnaires' disease has been steadily increasing over the last two decades. Because symptoms often mirror typical community-acquired pneumonia, many cases go undiagnosed, making accurate prevalence data difficult to establish on a global scale.

Who is most at risk for Legionnaires' disease?

Legionnaires' disease primarily affects adults, particularly those over the age of 50. While anyone can contract the infection, specific groups face higher risks. Factors influencing the distribution of Legionnaires' disease include:

• Age: Individuals aged 50 years and older are at the highest risk.


• Immune Status: Patients with chronic lung disease, diabetes, or weakened immune systems are more susceptible.


• Gender: Men are statistically more likely to be diagnosed with Legionnaires' disease than women, though the reasons for this disparity remain a subject of epidemiological study.


• Environmental Exposure: Outbreaks are often linked to contaminated water systems in large buildings, such as hotels, hospitals, or cooling towers.

Why is prevalence data for Legionnaires' disease challenging to track?

Tracking the exact number of people living with or recovering from Legionnaires' disease is difficult because it is an acute illness that requires specific laboratory testing—such as a urinary antigen test—to confirm. At DiseaseMaps.org, 5 members have shared their experiences with Legionnaires' disease, providing a vital, real-world perspective on the long-term recovery process that clinical statistics often overlook.

Next steps

• Consult an infectious disease specialist if you suspect respiratory complications following exposure to large building water systems.


• Report suspected outbreaks to your local public health department to aid in environmental surveillance.


• Join the DiseaseMaps community to connect with others who have navigated the recovery process from Legionnaires' disease.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment.

References

• Centers for Disease Control and Prevention (CDC): Legionella (Legionnaires' Disease and Pontiac Fever) Statistics.


• National Institutes of Health (NIH) GARD: Legionella pneumophila infection information.


• World Health Organization (WHO): Legionellosis fact sheets and global surveillance data.